NFE2L2 and heart failure: In addition, etomidate activates NRF2/HO-1 by promoting nuclear translocation of NRF2 to suppress IRI-induced ferroptosis and attenuate heart failure, pathological injury, myocardial fibrosis, and inflammation [53,64].